How frontal‑brain dopamine and norepinephrine influence motivation and movement circuits
Role of cortical catecholamines in regulating motivated behavior and striatal dopamine
['FUNDING_R01'] · UNIVERSITY OF FLORIDA · NIH-11308709
This work looks at how two brain chemicals in the frontal cortex—dopamine and norepinephrine—control motivation and the brain circuits that support movement and decision‑making, aiming to help people with dementia and other psychiatric conditions.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-11308709 on ClinicalTrials.gov |
What this research studies
From a patient viewpoint, scientists use precise lab tools to switch on or off specific frontal‑cortex cell groups and measure dopamine signals deep in the brain while animals perform tasks that model motivation and decision making. They combine chemogenetics to control circuits, fiber photometry to record dopamine dynamics, and behavioral tests to see how changes affect goal‑directed actions. The team will tease apart roles of cortical dopamine versus norepinephrine and of different prefrontal cell types in shaping striatal dopamine and motivated behavior. Findings are intended to point toward new targets for treating cognitive and motivational problems.
Who could benefit from this research
Good fit: People with dementia, Parkinson‑related motivational problems, or psychiatric conditions that cause impaired decision‑making and low motivation would be the most relevant groups for future therapies informed by this research.
Not a fit: People whose symptoms stem from nonneurological causes or from conditions unrelated to frontal‑striatal catecholamine signaling are less likely to benefit from findings of this project.
Why it matters
Potential benefit: If successful, this work could point to new ways to treat problems with motivation, decision‑making, and cognitive flexibility in dementia and certain psychiatric disorders.
How similar studies have performed: Animal studies have previously shown that changing cortical catecholamines alters motivation and cognition, but turning those findings into safe, effective human treatments remains largely unproven.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: URS, NIKHIL — UNIVERSITY OF FLORIDA
- Study coordinator: URS, NIKHIL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.